Vaccine Storage and Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Vaccine Storage {Refrigerators, Freezers}, Vaccine Packaging {Cold Boxes, Vials & Ampoules, Corrugated Boxes, Bags, Others}), By Packaging Material (Plastic, Glass, Paper & Paperboard, Others), By End User (Pharma and Biotech Companies, Diagnostic Centers, Clinical Research Organization, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 25.71 Billion
CAGR (2026-2031)	11.83%
Fastest Growing Segment	Glass
Largest Market	North America
Market Size (2031)	USD 50.29 Billion

Market Overview

The Global Vaccine Storage and Packaging Market is projected to grow from USD 25.71 Billion in 2025 to USD 50.29 Billion by 2031 at a 11.83% CAGR. The Global Vaccine Storage and Packaging Market encompasses the materials, equipment, and systems vital for maintaining vaccine efficacy, safety, and stability throughout the supply chain, from manufacturing to administration. Market growth is primarily driven by escalating global vaccination initiatives and the increasing demand for diverse vaccines worldwide. For instance, according to Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization, their "Big Catch-Up" initiative delivered over 100 million vaccine doses to approximately 18.3 million children across 36 countries between 2023 and 2025, with final program implementation concluding in March 2026. This massive distribution effort necessitates robust storage and packaging solutions. Furthermore, according to the World Health Organization and UNICEF, in 2024, approximately 115 million infants globally received at least one dose of the diphtheria, tetanus, and pertussis (DTP)-containing vaccine.

A significant challenge impeding market expansion is the substantial capital and operational expenditure associated with establishing and maintaining highly specialized cold chain infrastructure, particularly for ultra-low temperature requirements. The logistical complexities and the need for consistent temperature control across varied geographical regions add considerable financial and operational burdens to the supply chain.

Key Market Drivers

Rising global vaccine demand directly fuels the need for advanced storage and packaging solutions. As immunization programs expand and new vaccines are introduced, the volume of doses requiring careful handling escalates. According to the UNICEF Supply Annual Report 2025, published in April 2026, UNICEF procured US$2.446 billion in vaccines during 2025 to support global health initiatives. This substantial procurement underscores continuous supply requirements that necessitate robust primary and secondary packaging, ensuring vaccine integrity and safety from manufacturing facilities to administration points. The expansion of disease coverage, including new vaccines, further contributes to this escalating demand.

Concurrently, significant investments in cold chain infrastructure are a critical market driver. Maintaining precise temperature control is paramount for vaccine efficacy, especially for sensitive biological formulations. These investments include sophisticated refrigeration units, ultra-low temperature freezers, and temperature-monitoring devices, all requiring specialized packaging to function optimally within the cold chain. According to the UNICEF Supply Annual Report 2025, released in April 2026, the organization allocated US$144 million for cold chain equipment in 2025, highlighting ongoing efforts to bolster global distribution networks. The broader biopharmaceutical sector's robust activity also significantly impacts related infrastructure development. According to R&D World, in January 2026, global life sciences M&A investment reached $240 billion in 2025, reflecting substantial capital flow into areas supporting advanced drug delivery, including specialized packaging and storage.

Download Free Sample Report

Key Market Challenges

The substantial capital and operational expenditures associated with establishing and maintaining highly specialized cold chain infrastructure present a significant impediment to the Global Vaccine Storage and Packaging Market's growth. The stringent requirements for ultra-low temperature environments, crucial for many modern vaccine formulations, necessitate considerable upfront investments in advanced refrigeration units, robust monitoring systems, and reliable backup power solutions. These initial financial outlays create a significant barrier to entry for new market participants and constrain the expansion initiatives of existing providers. Furthermore, ongoing operational costs, encompassing substantial energy consumption, specialized personnel training, and continuous regulatory compliance, impose sustained financial burdens throughout the vaccine supply chain.

These elevated financial and logistical complexities directly hamper market expansion by restricting the widespread adoption and deployment of advanced vaccine storage and packaging solutions, particularly in resource-limited regions. Maintaining consistent temperature control across diverse transport modalities and varied climates demands sophisticated and expensive equipment and dedicated logistics services. This directly increases vaccine delivery costs, potentially slowing vaccination campaigns and tempering demand for associated storage and packaging components. According to the International Society for Pharmaceutical Engineering (ISPE), in 2025, establishing a compliant U.S. cold storage facility could cost upwards of $2 million, excluding maintenance and energy. This considerable capital requirement limits investment, thus hindering market growth.

Key Market Trends

The Global Vaccine Storage and Packaging Market is significantly influenced by the development of specialized ultra-low temperature solutions for mRNA vaccines. These advanced vaccine formulations require exceptionally stringent temperature control, often necessitating storage at temperatures between -60°C and -90°C to preserve their delicate biological integrity and potency. This requirement compels innovation in packaging and storage systems, driving demand for purpose-built ultra-low temperature freezers, insulated shipping containers, and sophisticated temperature-monitoring devices capable of maintaining these extreme conditions throughout distribution. This trend is crucial as the scope of mRNA vaccine technology expands beyond its initial applications. According to the World Health Organization, May 2025, more than 40 different mRNA vaccines targeting COVID-19 were under clinical trials, highlighting a sustained need for such specialized infrastructure.

Another major trend impacting the market is the shift toward prefilled syringes and unit-dose packaging. This packaging evolution streamlines vaccine administration by providing ready-to-use formats that reduce preparation time, minimize the risk of dosage errors, and decrease vaccine waste. Prefilled syringes enhance operational efficiency in various vaccination settings, from clinical environments to remote areas, by simplifying logistics and reducing the number of components required for each immunization. This advancement significantly influences the design and manufacturing of primary and secondary packaging, focusing on sterility, durability, and user-friendliness for healthcare professionals and patients alike. According to Contract Pharma, January 2026, BD is investing $110 million to expand its production of prefillable syringes, underscoring the industry's focus on this efficient delivery method.

Segmental Insights

The Global Vaccine Storage and Packaging Market observes glass as the fastest-growing segment, primarily due to its essential role in preserving vaccine integrity and efficacy. Glass offers superior chemical inertness, preventing adverse reactions between the packaging and sensitive vaccine formulations, including complex biologics and mRNA-based products. Furthermore, its excellent barrier properties shield vaccines from environmental factors such as moisture, oxygen, and light, which can cause degradation. Glass also withstands rigorous sterilization processes and maintains stability across diverse temperature ranges, critical for maintaining the cold chain. Adherence to stringent regulatory standards and quality assurance protocols, often overseen by bodies like the FDA and reflected in pharmacopeia requirements, reinforces the preference for glass in ensuring vaccine safety and long-term stability.

Regional Insights

North America holds a leading position in the global vaccine storage and packaging market, primarily driven by its robust healthcare infrastructure and extensive government initiatives supporting widespread immunization programs. The region’s dominance is substantially reinforced by stringent regulatory frameworks, notably those enforced by the U.S. Food and Drug Administration (FDA) and Health Canada, which necessitate high-quality storage and packaging solutions to maintain vaccine efficacy and safety across the entire supply chain. Furthermore, advanced cold chain infrastructure and a well-established pharmaceutical and biopharmaceutical industry contribute to the adoption of innovative storage and packaging technologies.

Recent Developments

• In February 2026, Aramis Biotechnologies Inc. and the Biologics Manufacturing Centre (BMC) Inc. announced a significant achievement through their collaboration: the successful completion of formulation, aseptic fill-finish, and clinical packaging activities. This joint effort was specifically for Aramis' seasonal influenza vaccine candidate, which is progressing towards Phase 1/2 clinical studies. The BMC contributed its specialized expertise in sterile manufacturing and packaging to ensure the clinical material adhered to all necessary quality, safety, and regulatory compliance standards. This partnership exemplifies ongoing efforts within the global vaccine packaging market to establish robust manufacturing and packaging solutions for emerging vaccine candidates.
• In January 2026, Becton, Dickinson and Company (BD) announced a substantial investment of $110 million aimed at expanding its manufacturing capabilities for BD Neopak™ Glass Prefillable Syringes. This expansion, situated in Columbus, Nebraska, is specifically intended to cater to the growing demand for biologic drug delivery systems, including those utilized for various vaccines. The initiative is anticipated to generate 120 new job positions and is designed to strengthen the resilience of the U.S. supply chain for injectable packaging solutions. This development directly addresses the critical need for reliable and scalable primary packaging within the global vaccine storage and packaging market.
• In December 2025, West Pharmaceutical Services, Inc. introduced an innovative next-generation ready-to-use sterile vial packaging solution. This new product features advanced barrier coatings specifically engineered to significantly extend vaccine shelf life. The enhanced barrier technology also works to mitigate contamination risks often encountered during cold-chain transportation, which is crucial for maintaining the integrity of sensitive biologics. This product launch directly responds to the market’s escalating demand for high-stability packaging solutions, highlighting advancements in the global vaccine storage and packaging sector by offering improved protection and reliability for pharmaceutical products.
• In April 2025, Stablepharma commenced a Phase I clinical trial for its tetanus-diphtheria vaccine candidate, SPVX02, which has been designed to remain stable at room temperature. This breakthrough research aims to circumvent the traditional requirement for cold chain storage, a factor that is associated with considerable vaccine wastage globally. The company reported that initial assessments confirmed the vaccine’s full potency even after exposure to extreme temperature fluctuations. The successful development and subsequent commercialization of such a thermostable vaccine would signify a transformative advancement in the global vaccine storage and packaging market, enhancing accessibility and simplifying logistical challenges.

Key Market Players

• Thermo Fisher Scientific Inc.
• McKesson Corporation
• Cencora, Inc.
• Cardinal Health, Inc.
• Deutsche Post AG
• DSV A/S
• United Parcel Service, Inc.
• FedEx Corporation
• PHC Holdings Corporation
• Azenta, Inc.

By Product Type	By Packaging Material	By End User	By Region
Vaccine Storage {Refrigerators Freezers} Vaccine Packaging {Cold Boxes Vials & Ampoules Corrugated Boxes Bags Others}	Plastic Glass Paper & Paperboard Others	Pharma and Biotech Companies Diagnostic Centers Clinical Research Organization Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vaccine Storage and Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vaccine Storage and Packaging Market, By Product Type:

• Vaccine Storage {Refrigerators
• Freezers}
• Vaccine Packaging {Cold Boxes
• Vials & Ampoules
• Corrugated Boxes
• Bags
• Others}

• Vaccine Storage and Packaging Market, By Packaging Material:

• Plastic
• Glass
• Paper & Paperboard
• Others

• Vaccine Storage and Packaging Market, By End User:

• Pharma and Biotech Companies
• Diagnostic Centers
• Clinical Research Organization
• Others

• Vaccine Storage and Packaging Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE